Disease/Infection News

RSS
Study indicates that SARS-CoV-2 has evolved to gain increased replicative fitness and become well-adapted in epithelial cells of human airways

Study indicates that SARS-CoV-2 has evolved to gain increased replicative fitness and become well-adapted in epithelial cells of human airways

Protein OCLN found to play crucial role in SARS-CoV-2 cell-to-cell transmission

Protein OCLN found to play crucial role in SARS-CoV-2 cell-to-cell transmission

Observational cohort study of long COVID among 2 million elderly adults

Observational cohort study of long COVID among 2 million elderly adults

Early use of dexamethasone associated with reduced mortality in hospitalized COVID-19 requiring breathing support

Early use of dexamethasone associated with reduced mortality in hospitalized COVID-19 requiring breathing support

Can SARS-CoV-2 infection cause diabetes?

Can SARS-CoV-2 infection cause diabetes?

Climate change poses risks to aquaculture, threatening food security

Climate change poses risks to aquaculture, threatening food security

First-in-human clinical study begins investigating the duoCAR T-cell therapy for treatment of HIV

First-in-human clinical study begins investigating the duoCAR T-cell therapy for treatment of HIV

Infectious particles of the SARS-CoV-2 virus isolated from hospital air

Infectious particles of the SARS-CoV-2 virus isolated from hospital air

Next-generation vaccine strategies to combat current and emerging SARS-CoV-2 variants

Next-generation vaccine strategies to combat current and emerging SARS-CoV-2 variants

Understanding the probable transmission of SARS-CoV-2 from lion to zookeepers

Understanding the probable transmission of SARS-CoV-2 from lion to zookeepers

Is there an association between exposure to ultrafine particles during pregnancy and influenza infection severity?

Is there an association between exposure to ultrafine particles during pregnancy and influenza infection severity?

Discovery offers a potential target for TB therapies

Discovery offers a potential target for TB therapies

Assessing the efficacy, safety and tolerability of AXA1125 in long COVID patients

Assessing the efficacy, safety and tolerability of AXA1125 in long COVID patients

ChatGPT-4 outperforms GPT-3.5 and Google Bard in neurosurgery oral board exam

ChatGPT-4 outperforms GPT-3.5 and Google Bard in neurosurgery oral board exam

Adapting for endemic not pandemic: Time to reassess universal masking in healthcare

Adapting for endemic not pandemic: Time to reassess universal masking in healthcare

Global study reveals diet's role in 70% of new type 2 diabetes cases

Global study reveals diet's role in 70% of new type 2 diabetes cases

COVID-19's hidden toll: Study reveals greater mortality disparities for people with intellectual disabilities

COVID-19's hidden toll: Study reveals greater mortality disparities for people with intellectual disabilities

Unlocking the potential of RNA lipid nanoparticles to revolutionize cancer treatment

Unlocking the potential of RNA lipid nanoparticles to revolutionize cancer treatment

Study reveals DCAF1 protein's role in colon cancer development through EZH2 phosphorylation

Study reveals DCAF1 protein's role in colon cancer development through EZH2 phosphorylation

New DCFHP-alum COVID-19 vaccine candidate shows durable, broad-spectrum protection in non-human primates

New DCFHP-alum COVID-19 vaccine candidate shows durable, broad-spectrum protection in non-human primates

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.